Dr. Shishir Seth

Dr. Shishir Seth
Country:
City:
Department:
Experience: 12 years of experience
Hospital: Indraprastha Apollo Hospital, New Delhi

About

About Dr. Shishir Seth Dr. Shishir Seth is a well-known Haematologist practicing successfully for more than 14 years. He is skilled in treating patients suffering from Acute Leukaemia (AML/ ALL), Lymphoma, Multiple Myeloma, CML, CLL, Chronic Myeloproliferative Neoplasm, Myelodysplastic syndrome as well as anemia, Thalassemia, Bleeding and clotting disorders. In his career, he has performed 150 Hematopoietic BMT, 40% of which was allogenic including Haplo-identical and antigen mismatch transplantations. He has also performed 300 induction therapies for acute leukemia. Dr. Shishir is the Life Member of the Indian Society of Haematology and Transfusion Medicine and a member of American Society of Clinical Oncology and American Society of Haematology. He takes a keen interest in research and has several publications to his credit in National and International journals.

List of Treatments

  • Aplastic Anemia
  • Myelodysplastic Syndrome (MDS) Treatment – Preleukemia
  • Allogeneic Bone Marrow Transplant
  • Thalassemia Treatment
  • Bone Marrow Transplant
  • Autologous Bone Marrow Transplant
  • Sickle Cell Anemia

Work Experience

, Junior resident, Seth G.S. Medical College & KEM hospital, Mumbai, India.

, Senior AMO, Bombay Hospital, Mumbai.

, Clinical Assistant, Haematology, PD Hinduja National Hospital, Mumbai.

, Senior Resident, GTB Hospital, New Delhi.

Consultant, Moolchand Hospital

Senior Resident, (DM-Clinical Haematology), Seth G.S. Medical College & KEM hospital, Mumbai, India

Consultant, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi

Consultant, Indraprastha Apollo Hospital, New Delhi

Special Interest

Haemato-Oncology
Leukaemia
Acute Leukaemia (AML/ ALL)
Lymphoma
Multiple Myeloma
Bone Marrow Transplant
CML
CLL
Chronic Myeloproliferative Neoplasm
Myelodysplastic syndrome
Anemia
Thalassemia
Bleeding and clotting disorders
Induction therapies for acute leukemia